EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.43 | apolipoprotein A-I | - |
Homo sapiens |
EC Number | Application | Comment | Organism |
---|---|---|---|
2.3.1.43 | medicine | haptoglobin from psoriatic patients exhibits decreased activity in binding haemoglobin and inhibiting LCAT | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.43 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.3.1.43 | blood plasma | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.43 | cholesterol + egg lecithin | - |
Homo sapiens | cholesteryl ester + ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.43 | LCAT | - |
Homo sapiens |
2.3.1.43 | lecithin-cholesterol acyltransferase | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.3.1.43 | 37 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.3.1.43 | 8 | - |
assay at | Homo sapiens |